INSL3 plays a role in the balance between bone formation and resorption

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 219-220

  Pepe, Anastasia ^a   Ferlin, Alberto ^a   Gianesello, Lisa ^a   Facciolli, Arianna ^a   Agoulnik, Alexander I ^b   Foresta, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Bone; INSL3; Osteoblast; Osteoporosis; RXFP2

Indexed keywords

INSULIN LIKE FACTOR 3; UNCLASSIFIED DRUG;

ADULT; BONE MASS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; IN VITRO SELECTION; MALE; NORMAL HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; RXFP2 GENE;

MUS;

EID: 64549084967     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03785.x     Document Type: Conference Paper

References (1)

1. Ferlin A., A. Pepe, L. Gianesello, et al. 2008. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J. Bone Miner. Res. 23: 683-693.